Matthew R. Henn, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 4,170 shares at $1.08 ($5K) on 2024-02-16, disclosed to the SEC on 2024-02-16.
Scheduled sale ($5k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MCRB | SELL | 2024-10-29 | $3K | — | Filing → |
| MCRB | SELL | 2024-08-19 | $775 | — | Filing → |
| MCRB | SELL | 2024-05-17 | $838 | — | Filing → |